Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Benign Prostatic Hyperplasia (BPH), commonly known as an enlarged prostate, is a non-cancerous condition that affects a significant percentage of older men. As the prostate gland grows, it can press on the urethra, leading to a range of urinary symptoms that can impact quality of life. While BPH is not life-threatening, its symptoms can be bothersome and require management.
Symptoms of BPH can include a frequent urge to urinate, difficulty starting urination, a weak stream, waking up frequently at night to urinate (nocturia), and a feeling of incomplete bladder emptying. These symptoms arise because the enlarged prostate squeezes the urethra, obstructing the flow of urine.
The exact causes of BPH are not fully understood, but hormonal changes associated with aging, particularly the decline in testosterone and the relative increase in estrogen, are believed to play a significant role. Androgens, like dihydrotestosterone (DHT), also contribute to prostate growth. This understanding of hormonal influence has led to the investigation of various therapeutic approaches, including those that modulate hormone levels.
In some regions, particularly Japan, synthetic progestogens have been explored for their potential in treating BPH. Allylestrenol, a synthetic progestogen known for its progestational activity and lack of androgenic effects, has been studied for its ability to help manage BPH symptoms. The proposed mechanism involves its antigonadotropic effects, which can lead to a decrease in testosterone and dihydrotestosterone levels. By reducing these androgens, Allylestrenol may help to inhibit prostate gland growth and alleviate urinary symptoms associated with BPH.
While Allylestrenol's primary applications are in obstetrics, its exploration in men's health conditions like BPH highlights the diverse pharmacological actions of progestogens. Although its use for BPH is not as widespread as other established treatments like alpha-blockers or 5-alpha-reductase inhibitors, it represents an area of continued research and interest. Patients experiencing BPH symptoms should always consult a healthcare provider to discuss the most appropriate and effective treatment options based on their individual health profile.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
